Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Parasitic Diseases

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 17 articles:
HTML format



Single Articles


    September 2022
  1. MUSA AM, Mbui J, Mohammed R, Olobo J, et al
    Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.
    Clin Infect Dis. 2022 Sep 27. pii: 6718130. doi: 10.1093.
    PubMed     Abstract available


    June 2022
  2. WEBSTER R, Mitchell H, Peters JM, Heunis J, et al
    Transmission blocking activity of low dose tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum.
    Clin Infect Dis. 2022 Jun 22. pii: 6613332. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  3. NIANG M, Sandfort M, Mbodj AF, Diouf B, et al
    Correction to: Fine-scale Spatiotemporal Mapping of Asymptomatic and Clinical Plasmodium falciparum Infections: Epidemiological Evidence for Targeted Malaria Elimination Interventions.
    Clin Infect Dis. 2022 Apr 26. pii: 6574503. doi: 10.1093.
    PubMed    


  4. IPPOLITO MM, Kabuya JB, Hauser M, Kamavu LK, et al
    Whole blood transfusion for severe malarial anemia in a high Plasmodium falciparum transmission setting.
    Clin Infect Dis. 2022 Apr 19. pii: 6570805. doi: 10.1093.
    PubMed     Abstract available


  5. CARVALHO AM, Viana SM, Andrade BB, Oliveira F, et al
    Immune response to LinB13, a Lutzomyia intermedia salivary protein correlates with disease severity in tegumentary leishmaniasis.
    Clin Infect Dis. 2022 Apr 6. pii: 6564311. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  6. BURZA S, Mahajan R, Kazmi S, Alexander N, et al
    AmBisome monotherapy and combination AmBisome - miltefosine therapy for the treatment of visceral leishmaniasis in patients co-infected with HIV in India: a randomised open label, parallel arm, phase 3 trial.
    Clin Infect Dis. 2022 Feb 11. pii: 6527047. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  7. MOHANTY S, Sahu PK, Pattnaik R, Majhi M, et al
    Evidence of Brain Alterations in Noncerebral Falciparum Malaria.
    Clin Infect Dis. 2021 Dec 15. pii: 6460593. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  8. OUATTARA M, Bassa FK, Diakite NR, Hattendorf J, et al
    Effectiveness of Four Different Interventions against Schistosoma haematobium in a Seasonal Transmission Setting of Cote d'Ivoire: A Cluster Randomized Trial.
    Clin Infect Dis. 2021 Sep 14. pii: 6369964. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  9. SCHMITT EK, Ndayisaba G, Yeka A, Asante KP, et al
    Efficacy of cipargamin (KAE609) in a randomized, Phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria.
    Clin Infect Dis. 2021 Aug 19. pii: 6354946. doi: 10.1093.
    PubMed     Abstract available


  10. CLARK J, Arinaitwe M, Nankasi A, Faust CL, et al
    Reconciling egg- and antigen-based estimates of Schistosoma mansoni clearance and reinfection: a modelling study.
    Clin Infect Dis. 2021 Aug 6. pii: 6343396. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  11. FAN H, Gai W, Zhang L, Ma Y, et al
    Parasite Circulating Cell-free DNA in the Blood of Alveolar Echinococcosis Patients as a Diagnostic and Treatment-Status Indicator.
    Clin Infect Dis. 2021;73:e246-e251.
    PubMed     Abstract available


    May 2021
  12. KAMRAN M, Ejazi SA, Choudhury ST, Bhattacharyya A, et al
    A novel antigen, otubain cysteine peptidase of Leishmania donovani improves serodiagnosis of visceral leishmaniasis and monitors treatment response.
    Clin Infect Dis. 2021 May 13. pii: 6275590. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  13. AYABINA D, Kura K, Toor J, Graham M, et al
    Maintaining low prevalence of Schistosoma mansoni: modelling the effect of less frequent treatment.
    Clin Infect Dis. 2021 Apr 28. pii: 6256990. doi: 10.1093.
    PubMed     Abstract available


  14. COFFENG LE, Le Rutte EA, Munoz J, Adams E, et al
    Antibody and antigen prevalence as indicators of ongoing transmission or elimination of visceral leishmaniasis: a modelling study.
    Clin Infect Dis. 2021 Apr 27. pii: 6255961. doi: 10.1093.
    PubMed     Abstract available


  15. COFFENG LE, Levecke B, Hattendorf J, Walker M, et al
    Survey design to monitor drug efficacy for the control of soil-transmitted helminthiasis and schistosomiasis.
    Clin Infect Dis. 2021 Apr 27. pii: 6255959. doi: 10.1093.
    PubMed     Abstract available


  16. SUMNER KM, Freedman E, Mangeni JN, Obala AA, et al
    Exposure to diverse Plasmodium falciparum genotypes shapes the risk of symptomatic malaria in incident and persistent infections: A longitudinal molecular epidemiologic study in Kenya.
    Clin Infect Dis. 2021 Apr 27. pii: 6255633. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  17. STEINHARDT LC, Richie TL, Yego R, Akach D, et al
    Safety, tolerability, and immunogenicity of PfSPZ Vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya.
    Clin Infect Dis. 2019 Sep 26. pii: 5573993. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parasitic Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: